Article(id=1329905903542841907, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905851004990344, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.09.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1746720000000, receivedDateStr=2025-05-09, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795003875860, onlineDateStr=2026-11-18, pubDate=1757433600000, pubDateStr=2025-09-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795003875860, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795003875860, creator=13701087609, updateTime=1795003875860, updator=13701087609, issue=Issue{id=1329905851004990344, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='9', pageStart='1109', pageEnd='1242', issueExtLink='null', onlineDate='null', pubDate='1757433600000', pubDateStr='2025-09-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1795003863334, creator='13701087609', updateTime=1795004352009, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329907901218533896, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905851004990344, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329907901218533897, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905851004990344, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1109, endPage=1117, ext={EN=ArticleExt(id=1329905903752557108, articleId=1329905903542841907, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Advances in Natural Products Targeting PRDX1 for Antitumor Therapy, columnId=1325194059773522066, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives & Review, runingTitle=null, highlight=null, articleAbstract=

Reactive oxygen species(ROS) are byproducts of cellular redox metabolism. Excessive ROS can lead to oxidative damage of DNA, proteins and lipids, thereby exacerbating the genetic instability of cancer cells and promoting tumor initiation and progression. Peroxiredoxin 1(PRDX1), a key member of the peroxidase family, plays a pivotal role in maintaining intracellular ROS balance, effectively protecting cells from ROS-induced damage. Simultaneously, PRDX1 acts as a molecular chaperone in various malignancies, exhibiting dual roles in either promoting or inhibiting tumor growth. In recent years, numerous PRDX1-targeting candidate drugs have demonstrated significant antitumor effects both in vitro and in vivo, confirming PRDX1 as a potential target for cancer therapy. This review summarizes recent advances in understanding the mechanisms of PRDX1 as a tumor treatment target, as well as the development of antitumor natural products targeting PRDX1.

, authors=Yanting PANG1, Qingyan SUN1, *, Weidong ZHANG1, 2, authorsList=Yanting PANG, Qingyan SUN, Weidong ZHANG, authorCompany=null, correspAuthors=Qingyan SUN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329905904029381173, articleId=1329905903542841907, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=靶向PRDX1的抗肿瘤天然产物研究进展, columnId=1322624444544176331, journalTitle=中国医药工业杂志, columnName=专论与综述, runingTitle=null, highlight=null, articleAbstract=

活性氧(ROS)是机体氧化还原的代谢产物。过量的ROS会导致DNA、蛋白质和脂质等氧化损伤,进而加剧肿瘤细胞的遗传不稳定性,促进肿瘤的发生和发展。过氧化物还原酶1(PRDX1)作为过氧化物酶家族的重要成员,在维持细胞内ROS平衡方面起着关键作用,可有效保护细胞免受ROS的损害。同时,PRDX1在多种恶性肿瘤中扮演分子伴侣的角色,表现出促进或抑制肿瘤的双重作用。近年来,多种靶向PRDX1的药物在体内外表现出显著的抗肿瘤效果,显示PRDX1是治疗恶性肿瘤的潜在靶点。文章综述了近年来PRDX1作为肿瘤治疗靶点的机制研究,并总结了已报道的靶向PRDX1的抗肿瘤天然产物研究进展。

, authors=庞艳婷1, 孙青䶮1, *, 张卫东1, 2, authorsList=庞艳婷, 孙青䶮, 张卫东, authorCompany=null, correspAuthors=孙青䶮, authorNote=

庞艳婷,硕士,专业方向:生药学相关研究。

, correspAuthorsNote=
孙青䶮,博士,研究员,从事基于活性天然产物的全合成、结构修饰、成药性优化及创新药物发现。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=beY9Ph0+Vhev7vgKvQbvTA==, magXml=w1kSmpFbiHGo26wYmUSeYA==, pdfUrl=null, pdf=nrR/Ix7xw19sfgnPKIQ3Jg==, pdfFileSize=1103940, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=NvfI8nsLRoBKzFFNML2Qww==, mapNumber=null, fund=null)}, authors=[Author(id=1329905904406868541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905904478171711, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904406868541, language=EN, stringName=Yanting PANG, firstName=Yanting, middleName=null, lastName=PANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905904549474881, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904406868541, language=CN, stringName=庞艳婷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio={"content":"

庞艳婷,硕士,专业方向:生药学相关研究。

"}, bioImg=null, bioContent=

庞艳婷,硕士,专业方向:生药学相关研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905904272650806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, xref=1., ext=[AuthorCompanyExt(id=1329905904281039415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905904285233720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1329905904612389443, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905904687886917, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904612389443, language=EN, stringName=Qingyan SUN, firstName=Qingyan, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905904750801478, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904612389443, language=CN, stringName=孙青䶮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905904272650806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, xref=1., ext=[AuthorCompanyExt(id=1329905904281039415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905904285233720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1329905904813716040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905904893407819, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904813716040, language=EN, stringName=Weidong ZHANG, firstName=Weidong, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203
2.College of Pharmacy, Naval Medical University, Shanghai 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905904973099596, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904813716040, language=CN, stringName=张卫东, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203
2.海军军医大学药学院,上海 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905904272650806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, xref=1., ext=[AuthorCompanyExt(id=1329905904281039415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905904285233720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)]), AuthorCompany(id=1329905904339759673, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, xref=2., ext=[AuthorCompanyExt(id=1329905904348148282, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904339759673, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.College of Pharmacy, Naval Medical University, Shanghai 200433), AuthorCompanyExt(id=1329905904352342587, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904339759673, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.海军军医大学药学院,上海 200433)])])], keywords=[Keyword(id=1329905905077957197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=EN, orderNo=1, keyword=reactive oxygen species), Keyword(id=1329905905140871758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=EN, orderNo=2, keyword=peroxiredoxin 1), Keyword(id=1329905905195397711, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=EN, orderNo=3, keyword=antitumor therapy), Keyword(id=1329905905266700880, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=EN, orderNo=4, keyword=targeting therapy), Keyword(id=1329905905321226833, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=EN, orderNo=5, keyword=natural product), Keyword(id=1329905905405112914, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=EN, orderNo=6, keyword=research progress), Keyword(id=1329905905472221779, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=CN, orderNo=1, keyword=活性氧), Keyword(id=1329905905526747732, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=CN, orderNo=2, keyword=过氧化物还原酶1), Keyword(id=1329905905593856597, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=CN, orderNo=3, keyword=抗肿瘤治疗), Keyword(id=1329905905656771158, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=CN, orderNo=4, keyword=靶向治疗), Keyword(id=1329905905711297111, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=CN, orderNo=5, keyword=天然产物), Keyword(id=1329905905778405976, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, language=CN, orderNo=6, keyword=研究进展)], refs=[Reference(id=1329905905866486361, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=QIU T, AZIZI S A, PANI S, et al.Dynamic PRDX S-acylation modulates ROS stress and signaling [J].Cell Chem Biol, 2025, 32(3): 511-519.e5., articleTitle=null, refAbstract=null), Reference(id=1329905905925206618, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=GUAN X, RUAN Y Y, CHE X X, et al.Dual role of PRDX1 in redox-regulation and tumorigenesis: past and future [J].Free Radical Bio Med, 2024, 210: 120-129., articleTitle=null, refAbstract=null), Reference(id=1329905905992315483, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU H, LI L F, CHEN J, et al.Expression and prognostic value of PRDX family in colon adenocarcinoma by integrating comprehensive analysis and in vitro and in vivo validation [J].Front Oncol, 2023, 13: 1136738., articleTitle=null, refAbstract=null), Reference(id=1329905906051035740, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=SPÍNOLA-LASSO E, MONTERO J C, JIMÉNEZ-MONZÓN R, et al.Chemical- proteomics identify peroxiredoxin-1 as an actionable target in triple-negative breast cancer [J].Int J Biol Sci, 2023, 19(6): 1731-1747., articleTitle=null, refAbstract=null), Reference(id=1329905906118144605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=XU H, ZHAO H F, DING C Y, et al.Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1 [J].Signal Transduct Targeted Ther, 2023, 8(1): 51., articleTitle=null, refAbstract=null), Reference(id=1329905906189447774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=BOLDUC J, KORUZA K, LUO T, et al.Peroxiredoxins wear many hats: factors that fashion their peroxide sensing personalities [J].Redox Biol, 2021, 42: 101959., articleTitle=null, refAbstract=null), Reference(id=1329905906256556639, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LV C, HUANG Y, WANG Q, et al.Ainsliadimer A induces ROS-mediated apoptosis in colorectal cancer cells via directly targeting peroxiredoxin 1 and 2 [J].Cell Chem Biol, 2023, 30(3): 295-307., articleTitle=null, refAbstract=null), Reference(id=1329905906323665504, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=ATTARAN S, SKOKO J J, HOPKINS B L, et al.Peroxiredoxin-1 Tyr194 phosphorylation regulates LOX-dependent extracellular matrix remodelling in breast cancer[J].Br J Cancer, 2021, 125(8): 1146-1157., articleTitle=null, refAbstract=null), Reference(id=1329905906394968673, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=MORETTON A, KOURTIS S, ZAPATER A G, et al.A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability [J].Mol Syst Biol, 2023, 19(7): e11267., articleTitle=null, refAbstract=null), Reference(id=1329905906466271842, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=LIAO W W, DU J P, LI L, et al.CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma [J].J Exp Clin Cancer Res, 2023, 42(1): 125., articleTitle=null, refAbstract=null), Reference(id=1329905906541769315, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=SONG C S, XIONG G, YANG S L, et al.PRDX1 stimulates non-small-cell lung carcinoma to proliferate via the Wnt/β-catenin signaling [J].Panminerva Med, 2023, 65(1): 37-42., articleTitle=null, refAbstract=null), Reference(id=1329905906613072484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=SKOKO J J, CAO J X, GABORIAU D, et al.Redox regulation of RAD51 Cys319 and homologous recombination by peroxiredoxin 1 [J].Redox Biol, 2022, 56: 102443., articleTitle=null, refAbstract=null), Reference(id=1329905906680181349, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU J, LI X Y, LIU Y J, et al.Full-coverage regulations of autophagy by ROS: from induction to maturation [J].Autophagy, 2022, 18(6): 1240-1255., articleTitle=null, refAbstract=null), Reference(id=1329905906768261734, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG T, LI L L, MO X T, et al.Matairesinol blunts adverse cardiac remodeling and heart failure induced by pressure overload by regulating Prdx1 and PI3K/AKT/FOXO1 signaling [J].Phytomedicine, 2024, 135: 156054., articleTitle=null, refAbstract=null), Reference(id=1329905906839564903, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=XU S F, MA Y L, TONG Q C, et al.Cullin-5 neddylation-mediated NOXA degradation is enhanced by PRDX1 oligomers in colorectal cancer [J].Cell Death Dis, 2021, 12(3): 265., articleTitle=null, refAbstract=null), Reference(id=1329905906906673768, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=LI J, SUN Y C, ZHAO X, et al.Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells [J].Cell Death Dis, 2023, 14(4):259., articleTitle=null, refAbstract=null), Reference(id=1329905906982171241, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=DAHOU H, MINATI M-A, JACQUEMIN P, et al.Genetic inactivation of peroxiredoxin-Ⅰ impairs the growth of human pancreatic cancer cells [J].Antioxidants (Basel), 2021, 10(4): 570., articleTitle=null, refAbstract=null), Reference(id=1329905907061863018, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=HA B, KIM E K, KIM J H, et al.Human peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its peroxidase activity [J].Biochem Bioph Res Commun, 2012, 421(1): 33-37., articleTitle=null, refAbstract=null), Reference(id=1329905907124777579, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=JIANG Y Y, CAO W, WU K, et al.LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus [J].J Exp Clin Cancer Res, 2019, 38(1): 365., articleTitle=null, refAbstract=null), Reference(id=1329905907204469356, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=SUN Q K, ZHU J Y, WANG W, et al.Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma [J].Med Oncol, 2014, 31(1): 786., articleTitle=null, refAbstract=null), Reference(id=1329905907267383917, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=RIDDELL J R, MAIER P, SASS S N, et al.Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α [J].PLoS One, 2012, 7(11):e50394., articleTitle=null, refAbstract=null), Reference(id=1329905907321909870, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG R B, LIU Y T, LIU L, et al.Tumor cells induce LAMP2a expression in tumor-associated macrophage for cancer progression [J].EBioMedicine, 2019, 40: 118-134., articleTitle=null, refAbstract=null), Reference(id=1329905907384824431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=CAO J X, SCHULTE J, KNIGHT A, et al.PRDX1 inhibits tumorigenesis via regulating PTEN/AKT activity [J].EMBO J, 2009, 28(10): 1505-1517., articleTitle=null, refAbstract=null), Reference(id=1329905907443544688, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=MIN Y, KIM M J, LEE S, et al.Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation [J].Autophagy, 2018, 14(8): 1347-1358., articleTitle=null, refAbstract=null), Reference(id=1329905907514847857, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=JEZIERSKA-DRUTEL A, ATTARAN S, HOPKINS B L, et al.The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinases [J].Bmc Cancer, 2019, 19(1): 812., articleTitle=null, refAbstract=null), Reference(id=1329905907577762418, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI J F, LI J X, XU Z Y, et al.Celastrol: a review of useful strategies overcoming its limitation in anticancer application[J].Front Pharmacol, 2020, 11: 558741., articleTitle=null, refAbstract=null), Reference(id=1329905907632288371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=LI Y, ZHU Y Y, SHANG F F, et al.Discovery of urea derivatives of celastrol as selective peroxiredoxin 1 inhibitors against colorectal cancer cells [J].J Med Chem, 2024, 67(9): 7176-7196., articleTitle=null, refAbstract=null), Reference(id=1329905907695202932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=LEI Z C, LI N, YU N R, et al.Design and synthesis of novel celastrol derivatives as potential anticancer agents against gastric cancer cells [J].J Nat Prod, 2022, 85(5): 1282-1293., articleTitle=null, refAbstract=null), Reference(id=1329905907816837749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=BAI Y, LIANG C, ZHOU J W, et al.Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer [J].Eur J Med Chem, 2023, 259: 115656., articleTitle=null, refAbstract=null), Reference(id=1329905907879752310, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU C X, YIN Q Q, ZHOU H C, et al.Adenanthin targets peroxiredoxin Ⅰ and Ⅱ to induce differentiation of leukemic cells [J].Nat Chem Biol, 2012, 8(5): 486-493., articleTitle=null, refAbstract=null), Reference(id=1329905907938472567, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU H, WANG B, KONG L, et al.Parvifoline AA promotes susceptibility of hepatocarcinoma to natural killer cell-mediated cytolysis by targeting peroxiredoxin [J].Cell Chem Biol, 2019, 26(8): 1122-1132.e6., articleTitle=null, refAbstract=null), Reference(id=1329905908001387128, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU X F, LIANG Z, LI K L, et al.Exploring the natural piericidins as anti-renal cell carcinoma agents targeting peroxiredoxin 1 [J].J Med Chem, 2019, 62(15): 7058-7069., articleTitle=null, refAbstract=null), Reference(id=1329905908064301689, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=赵 潇, 任 贺, 高 松, 等.薯蓣皂苷对胰腺癌MiaPaCa-2细胞凋亡的影响及机制[J].中华肿瘤杂志, 2014, 36(1): 5-10., articleTitle=null, refAbstract=null), Reference(id=1329905908123021946, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=YE Q, ZHANG Y N, CAO Y N, et al.Frenolicin B targets peroxiredoxin 1 and glutaredoxin 3 to trigger ROS/4E-BP1-mediated antitumor effects [J].Cell Chem Biol, 2019, 26(3):366-377.e12., articleTitle=null, refAbstract=null), Reference(id=1329905908185936507, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=FENG L, WU T Z, GUO X R, et al.Discovery of natural resorcylic acid lactones as novel potent copper ionophores covalently targeting PRDX1 to induce cuproptosis for triple-negative breast cancer therapy [J].ACS Central Science, 2025, 11(2): 357-370., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329905904272650806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, xref=1., ext=[AuthorCompanyExt(id=1329905904281039415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905904285233720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)]), AuthorCompany(id=1329905904339759673, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, xref=2., ext=[AuthorCompanyExt(id=1329905904348148282, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904339759673, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.College of Pharmacy, Naval Medical University, Shanghai 200433), AuthorCompanyExt(id=1329905904352342587, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904339759673, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.海军军医大学药学院,上海 200433)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.09.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.09.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.09.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.09.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1757433600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
靶向PRDX1的抗肿瘤天然产物研究进展
庞艳婷 1 , 孙青䶮 1, * , 张卫东 1, 2
中国医药工业杂志 | 专论与综述 2025,56(9): 1109-1117
收起
收藏切换
中国医药工业杂志 |专论与综述 2025 , 56 (9) : 1109 -1117
靶向PRDX1的抗肿瘤天然产物研究进展
全屏
[Author(id=1329905904406868541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905904478171711, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904406868541, language=EN, stringName=Yanting PANG, firstName=Yanting, middleName=null, lastName=PANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905904549474881, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904406868541, language=CN, stringName=庞艳婷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio={"content":"

庞艳婷,硕士,专业方向:生药学相关研究。

"}, bioImg=null, bioContent=

庞艳婷,硕士,专业方向:生药学相关研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905904272650806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, xref=1., ext=[AuthorCompanyExt(id=1329905904281039415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905904285233720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1329905904612389443, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905904687886917, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904612389443, language=EN, stringName=Qingyan SUN, firstName=Qingyan, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905904750801478, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904612389443, language=CN, stringName=孙青䶮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905904272650806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, xref=1., ext=[AuthorCompanyExt(id=1329905904281039415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905904285233720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1329905904813716040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905904893407819, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904813716040, language=EN, stringName=Weidong ZHANG, firstName=Weidong, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203
2.College of Pharmacy, Naval Medical University, Shanghai 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905904973099596, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, authorId=1329905904813716040, language=CN, stringName=张卫东, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203
2.海军军医大学药学院,上海 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905904272650806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, xref=1., ext=[AuthorCompanyExt(id=1329905904281039415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905904285233720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904272650806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)]), AuthorCompany(id=1329905904339759673, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, xref=2., ext=[AuthorCompanyExt(id=1329905904348148282, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904339759673, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.College of Pharmacy, Naval Medical University, Shanghai 200433), AuthorCompanyExt(id=1329905904352342587, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905903542841907, companyId=1329905904339759673, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.海军军医大学药学院,上海 200433)])])]
庞艳婷1, 孙青䶮1, *, 张卫东1, 2
作者信息
  • 1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203
  • 2.海军军医大学药学院,上海 200433
通讯作者:
孙青䶮,博士,研究员,从事基于活性天然产物的全合成、结构修饰、成药性优化及创新药物发现。
作者简介:

庞艳婷,硕士,专业方向:生药学相关研究。

Advances in Natural Products Targeting PRDX1 for Antitumor Therapy
Yanting PANG1, Qingyan SUN1, *, Weidong ZHANG1, 2
Affiliations
  • 1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2.College of Pharmacy, Naval Medical University, Shanghai 200433
出版时间: 2025-09-10 doi: 10.16522/j.cnki.cjph.2025.09.001
文章导航
收藏切换

活性氧(ROS)是机体氧化还原的代谢产物。过量的ROS会导致DNA、蛋白质和脂质等氧化损伤,进而加剧肿瘤细胞的遗传不稳定性,促进肿瘤的发生和发展。过氧化物还原酶1(PRDX1)作为过氧化物酶家族的重要成员,在维持细胞内ROS平衡方面起着关键作用,可有效保护细胞免受ROS的损害。同时,PRDX1在多种恶性肿瘤中扮演分子伴侣的角色,表现出促进或抑制肿瘤的双重作用。近年来,多种靶向PRDX1的药物在体内外表现出显著的抗肿瘤效果,显示PRDX1是治疗恶性肿瘤的潜在靶点。文章综述了近年来PRDX1作为肿瘤治疗靶点的机制研究,并总结了已报道的靶向PRDX1的抗肿瘤天然产物研究进展。

活性氧  /  过氧化物还原酶1  /  抗肿瘤治疗  /  靶向治疗  /  天然产物  /  研究进展

Reactive oxygen species(ROS) are byproducts of cellular redox metabolism. Excessive ROS can lead to oxidative damage of DNA, proteins and lipids, thereby exacerbating the genetic instability of cancer cells and promoting tumor initiation and progression. Peroxiredoxin 1(PRDX1), a key member of the peroxidase family, plays a pivotal role in maintaining intracellular ROS balance, effectively protecting cells from ROS-induced damage. Simultaneously, PRDX1 acts as a molecular chaperone in various malignancies, exhibiting dual roles in either promoting or inhibiting tumor growth. In recent years, numerous PRDX1-targeting candidate drugs have demonstrated significant antitumor effects both in vitro and in vivo, confirming PRDX1 as a potential target for cancer therapy. This review summarizes recent advances in understanding the mechanisms of PRDX1 as a tumor treatment target, as well as the development of antitumor natural products targeting PRDX1.

reactive oxygen species  /  peroxiredoxin 1  /  antitumor therapy  /  targeting therapy  /  natural product  /  research progress
庞艳婷, 孙青䶮, 张卫东. 靶向PRDX1的抗肿瘤天然产物研究进展. 中国医药工业杂志, 2025 , 56 (9) : 1109 -1117 . DOI: 10.16522/j.cnki.cjph.2025.09.001
Yanting PANG, Qingyan SUN, Weidong ZHANG. Advances in Natural Products Targeting PRDX1 for Antitumor Therapy[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (9) : 1109 -1117 . DOI: 10.16522/j.cnki.cjph.2025.09.001

参考文献 引证文献
排序方式:
[1]
QIU T, AZIZI S A, PANI S, et al.Dynamic PRDX S-acylation modulates ROS stress and signaling [J].Cell Chem Biol, 2025, 32(3): 511-519.e5.
[2]
GUAN X, RUAN Y Y, CHE X X, et al.Dual role of PRDX1 in redox-regulation and tumorigenesis: past and future [J].Free Radical Bio Med, 2024, 210: 120-129.
[3]
ZHOU H, LI L F, CHEN J, et al.Expression and prognostic value of PRDX family in colon adenocarcinoma by integrating comprehensive analysis and in vitro and in vivo validation [J].Front Oncol, 2023, 13: 1136738.
[4]
SPÍNOLA-LASSO E, MONTERO J C, JIMÉNEZ-MONZÓN R, et al.Chemical- proteomics identify peroxiredoxin-1 as an actionable target in triple-negative breast cancer [J].Int J Biol Sci, 2023, 19(6): 1731-1747.
[5]
XU H, ZHAO H F, DING C Y, et al.Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1 [J].Signal Transduct Targeted Ther, 2023, 8(1): 51.
[6]
BOLDUC J, KORUZA K, LUO T, et al.Peroxiredoxins wear many hats: factors that fashion their peroxide sensing personalities [J].Redox Biol, 2021, 42: 101959.
[7]
LV C, HUANG Y, WANG Q, et al.Ainsliadimer A induces ROS-mediated apoptosis in colorectal cancer cells via directly targeting peroxiredoxin 1 and 2 [J].Cell Chem Biol, 2023, 30(3): 295-307.
[8]
ATTARAN S, SKOKO J J, HOPKINS B L, et al.Peroxiredoxin-1 Tyr194 phosphorylation regulates LOX-dependent extracellular matrix remodelling in breast cancer[J].Br J Cancer, 2021, 125(8): 1146-1157.
[9]
MORETTON A, KOURTIS S, ZAPATER A G, et al.A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability [J].Mol Syst Biol, 2023, 19(7): e11267.
[10]
LIAO W W, DU J P, LI L, et al.CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma [J].J Exp Clin Cancer Res, 2023, 42(1): 125.
[11]
SONG C S, XIONG G, YANG S L, et al.PRDX1 stimulates non-small-cell lung carcinoma to proliferate via the Wnt/β-catenin signaling [J].Panminerva Med, 2023, 65(1): 37-42.
[12]
SKOKO J J, CAO J X, GABORIAU D, et al.Redox regulation of RAD51 Cys319 and homologous recombination by peroxiredoxin 1 [J].Redox Biol, 2022, 56: 102443.
[13]
ZHOU J, LI X Y, LIU Y J, et al.Full-coverage regulations of autophagy by ROS: from induction to maturation [J].Autophagy, 2022, 18(6): 1240-1255.
[14]
ZHANG T, LI L L, MO X T, et al.Matairesinol blunts adverse cardiac remodeling and heart failure induced by pressure overload by regulating Prdx1 and PI3K/AKT/FOXO1 signaling [J].Phytomedicine, 2024, 135: 156054.
[15]
XU S F, MA Y L, TONG Q C, et al.Cullin-5 neddylation-mediated NOXA degradation is enhanced by PRDX1 oligomers in colorectal cancer [J].Cell Death Dis, 2021, 12(3): 265.
[16]
LI J, SUN Y C, ZHAO X, et al.Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells [J].Cell Death Dis, 2023, 14(4):259.
[17]
DAHOU H, MINATI M-A, JACQUEMIN P, et al.Genetic inactivation of peroxiredoxin-Ⅰ impairs the growth of human pancreatic cancer cells [J].Antioxidants (Basel), 2021, 10(4): 570.
[18]
HA B, KIM E K, KIM J H, et al.Human peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its peroxidase activity [J].Biochem Bioph Res Commun, 2012, 421(1): 33-37.
[19]
JIANG Y Y, CAO W, WU K, et al.LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus [J].J Exp Clin Cancer Res, 2019, 38(1): 365.
[20]
SUN Q K, ZHU J Y, WANG W, et al.Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma [J].Med Oncol, 2014, 31(1): 786.
[21]
RIDDELL J R, MAIER P, SASS S N, et al.Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α [J].PLoS One, 2012, 7(11):e50394.
[22]
WANG R B, LIU Y T, LIU L, et al.Tumor cells induce LAMP2a expression in tumor-associated macrophage for cancer progression [J].EBioMedicine, 2019, 40: 118-134.
[23]
CAO J X, SCHULTE J, KNIGHT A, et al.PRDX1 inhibits tumorigenesis via regulating PTEN/AKT activity [J].EMBO J, 2009, 28(10): 1505-1517.
[24]
MIN Y, KIM M J, LEE S, et al.Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation [J].Autophagy, 2018, 14(8): 1347-1358.
[25]
JEZIERSKA-DRUTEL A, ATTARAN S, HOPKINS B L, et al.The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinases [J].Bmc Cancer, 2019, 19(1): 812.
[26]
SHI J F, LI J X, XU Z Y, et al.Celastrol: a review of useful strategies overcoming its limitation in anticancer application[J].Front Pharmacol, 2020, 11: 558741.
[27]
LI Y, ZHU Y Y, SHANG F F, et al.Discovery of urea derivatives of celastrol as selective peroxiredoxin 1 inhibitors against colorectal cancer cells [J].J Med Chem, 2024, 67(9): 7176-7196.
[28]
LEI Z C, LI N, YU N R, et al.Design and synthesis of novel celastrol derivatives as potential anticancer agents against gastric cancer cells [J].J Nat Prod, 2022, 85(5): 1282-1293.
[29]
BAI Y, LIANG C, ZHOU J W, et al.Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer [J].Eur J Med Chem, 2023, 259: 115656.
[30]
LIU C X, YIN Q Q, ZHOU H C, et al.Adenanthin targets peroxiredoxin Ⅰ and Ⅱ to induce differentiation of leukemic cells [J].Nat Chem Biol, 2012, 8(5): 486-493.
[31]
ZHU H, WANG B, KONG L, et al.Parvifoline AA promotes susceptibility of hepatocarcinoma to natural killer cell-mediated cytolysis by targeting peroxiredoxin [J].Cell Chem Biol, 2019, 26(8): 1122-1132.e6.
[32]
ZHOU X F, LIANG Z, LI K L, et al.Exploring the natural piericidins as anti-renal cell carcinoma agents targeting peroxiredoxin 1 [J].J Med Chem, 2019, 62(15): 7058-7069.
[33]
赵 潇, 任 贺, 高 松, 等.薯蓣皂苷对胰腺癌MiaPaCa-2细胞凋亡的影响及机制[J].中华肿瘤杂志, 2014, 36(1): 5-10.
[34]
YE Q, ZHANG Y N, CAO Y N, et al.Frenolicin B targets peroxiredoxin 1 and glutaredoxin 3 to trigger ROS/4E-BP1-mediated antitumor effects [J].Cell Chem Biol, 2019, 26(3):366-377.e12.
[35]
FENG L, WU T Z, GUO X R, et al.Discovery of natural resorcylic acid lactones as novel potent copper ionophores covalently targeting PRDX1 to induce cuproptosis for triple-negative breast cancer therapy [J].ACS Central Science, 2025, 11(2): 357-370.
2025年第56卷第9期
36
9
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2025.09.001
  • 接收时间:2025-05-09
  • 首发时间:2026-11-18
  • 出版时间:2025-09-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-05-09
基金
作者信息
    1.中国医药工业研究总院上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203
    2.海军军医大学药学院,上海 200433

通讯作者:

孙青䶮,博士,研究员,从事基于活性天然产物的全合成、结构修饰、成药性优化及创新药物发现。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.09.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏